HEADER HYDROLASE/INHIBITOR 15-JUL-22 7YI7 TITLE CRYSTAL STRUCTURE OF HUMAN HPSE1 IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPARANASE 50 KDA SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 EC: 3.2.1.166; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: HEPARANASE 8 KDA SUBUNIT; COMPND 9 CHAIN: B; COMPND 10 EC: 3.2.1.166; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PIEX4; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1; SOURCE 15 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PIEX4 KEYWDS ENDO-GLUCORONIDASE, HEPARANASE-1, HEP, HPA, HPA1, HPR1, HPSE1, HSE1, KEYWDS 2 HYDROLASE, HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.MIMA,N.FUJIMOTO,Y.IMAI REVDAT 2 29-NOV-23 7YI7 1 REMARK REVDAT 1 07-DEC-22 7YI7 0 JRNL AUTH Y.IMAI,D.WAKASUGI,R.SUZUKI,S.KATO,M.SUGISAKI,M.MIMA, JRNL AUTH 2 H.MIYAGAWA,M.ENDO,N.FUJIMOTO,T.FUKUNAGA,S.KATO,S.KURODA, JRNL AUTH 3 T.TAKAHASHI,H.KAKINUMA JRNL TITL LEAD IDENTIFICATION OF NOVEL JRNL TITL 2 TETRAHYDROIMIDAZO[1,2-A]PYRIDINE-5-CARBOXYLIC ACID JRNL TITL 3 DERIVATIVE AS A POTENT HEPARANASE-1 INHIBITOR. JRNL REF BIOORG.MED.CHEM.LETT. V. 79 29050 2022 JRNL REFN ESSN 1464-3405 JRNL PMID 36368497 JRNL DOI 10.1016/J.BMCL.2022.129050 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0189 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.73 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 10902 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.400 REMARK 3 FREE R VALUE TEST SET COUNT : 621 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 795 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.76 REMARK 3 BIN R VALUE (WORKING SET) : 0.3700 REMARK 3 BIN FREE R VALUE SET COUNT : 37 REMARK 3 BIN FREE R VALUE : 0.3900 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3643 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 13 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 58.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.68000 REMARK 3 B22 (A**2) : 8.37000 REMARK 3 B33 (A**2) : -5.83000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -4.86000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.467 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.520 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 30.680 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.897 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3761 ; 0.011 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3548 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5095 ; 1.483 ; 1.983 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8229 ; 0.795 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 457 ; 6.357 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 159 ;37.865 ;23.459 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 647 ;17.248 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;16.389 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 567 ; 0.077 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4101 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 790 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1834 ; 3.963 ; 5.720 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1833 ; 3.961 ; 5.719 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2289 ; 6.424 ; 8.564 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2290 ; 6.423 ; 8.566 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1927 ; 3.588 ; 6.066 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1924 ; 3.588 ; 6.062 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2805 ; 6.073 ; 8.950 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 15124 ;11.754 ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 15124 ;11.754 ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 7YI7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-JUL-22. REMARK 100 THE DEPOSITION ID IS D_1300030957. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-OCT-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54184 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 200K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSALISPRO REMARK 200 DATA SCALING SOFTWARE : CRYSALISPRO REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11532 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 21.730 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 5E8M REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% W/V POLYETHYLENE GLYCOL 3,350, 100 REMARK 280 MM SODIUM MALONATE PH 4.0, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.04500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -57.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 158 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD1 ASP A 234 OXT GLU B 109 2545 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 233 20.95 -147.73 REMARK 500 THR A 333 -39.58 -132.56 REMARK 500 LEU A 355 -66.28 -139.71 REMARK 500 LEU A 419 -152.57 -99.92 REMARK 500 SER B 55 33.52 -84.85 REMARK 500 REMARK 500 REMARK: NULL DBREF 7YI7 A 158 543 UNP Q9Y251 HPSE_HUMAN 158 543 DBREF 7YI7 B 36 109 UNP Q9Y251 HPSE_HUMAN 36 109 SEQADV 7YI7 ARG A 307 UNP Q9Y251 LYS 307 ENGINEERED MUTATION SEQRES 1 A 386 LYS LYS PHE LYS ASN SER THR TYR SER ARG SER SER VAL SEQRES 2 A 386 ASP VAL LEU TYR THR PHE ALA ASN CYS SER GLY LEU ASP SEQRES 3 A 386 LEU ILE PHE GLY LEU ASN ALA LEU LEU ARG THR ALA ASP SEQRES 4 A 386 LEU GLN TRP ASN SER SER ASN ALA GLN LEU LEU LEU ASP SEQRES 5 A 386 TYR CYS SER SER LYS GLY TYR ASN ILE SER TRP GLU LEU SEQRES 6 A 386 GLY ASN GLU PRO ASN SER PHE LEU LYS LYS ALA ASP ILE SEQRES 7 A 386 PHE ILE ASN GLY SER GLN LEU GLY GLU ASP PHE ILE GLN SEQRES 8 A 386 LEU HIS LYS LEU LEU ARG LYS SER THR PHE LYS ASN ALA SEQRES 9 A 386 LYS LEU TYR GLY PRO ASP VAL GLY GLN PRO ARG ARG LYS SEQRES 10 A 386 THR ALA LYS MET LEU LYS SER PHE LEU LYS ALA GLY GLY SEQRES 11 A 386 GLU VAL ILE ASP SER VAL THR TRP HIS HIS TYR TYR LEU SEQRES 12 A 386 ASN GLY ARG THR ALA THR ARG GLU ASP PHE LEU ASN PRO SEQRES 13 A 386 ASP VAL LEU ASP ILE PHE ILE SER SER VAL GLN LYS VAL SEQRES 14 A 386 PHE GLN VAL VAL GLU SER THR ARG PRO GLY LYS LYS VAL SEQRES 15 A 386 TRP LEU GLY GLU THR SER SER ALA TYR GLY GLY GLY ALA SEQRES 16 A 386 PRO LEU LEU SER ASP THR PHE ALA ALA GLY PHE MET TRP SEQRES 17 A 386 LEU ASP LYS LEU GLY LEU SER ALA ARG MET GLY ILE GLU SEQRES 18 A 386 VAL VAL MET ARG GLN VAL PHE PHE GLY ALA GLY ASN TYR SEQRES 19 A 386 HIS LEU VAL ASP GLU ASN PHE ASP PRO LEU PRO ASP TYR SEQRES 20 A 386 TRP LEU SER LEU LEU PHE LYS LYS LEU VAL GLY THR LYS SEQRES 21 A 386 VAL LEU MET ALA SER VAL GLN GLY SER LYS ARG ARG LYS SEQRES 22 A 386 LEU ARG VAL TYR LEU HIS CYS THR ASN THR ASP ASN PRO SEQRES 23 A 386 ARG TYR LYS GLU GLY ASP LEU THR LEU TYR ALA ILE ASN SEQRES 24 A 386 LEU HIS ASN VAL THR LYS TYR LEU ARG LEU PRO TYR PRO SEQRES 25 A 386 PHE SER ASN LYS GLN VAL ASP LYS TYR LEU LEU ARG PRO SEQRES 26 A 386 LEU GLY PRO HIS GLY LEU LEU SER LYS SER VAL GLN LEU SEQRES 27 A 386 ASN GLY LEU THR LEU LYS MET VAL ASP ASP GLN THR LEU SEQRES 28 A 386 PRO PRO LEU MET GLU LYS PRO LEU ARG PRO GLY SER SER SEQRES 29 A 386 LEU GLY LEU PRO ALA PHE SER TYR SER PHE PHE VAL ILE SEQRES 30 A 386 ARG ASN ALA LYS VAL ALA ALA CYS ILE SEQRES 1 B 74 GLN ASP VAL VAL ASP LEU ASP PHE PHE THR GLN GLU PRO SEQRES 2 B 74 LEU HIS LEU VAL SER PRO SER PHE LEU SER VAL THR ILE SEQRES 3 B 74 ASP ALA ASN LEU ALA THR ASP PRO ARG PHE LEU ILE LEU SEQRES 4 B 74 LEU GLY SER PRO LYS LEU ARG THR LEU ALA ARG GLY LEU SEQRES 5 B 74 SER PRO ALA TYR LEU ARG PHE GLY GLY THR LYS THR ASP SEQRES 6 B 74 PHE LEU ILE PHE ASP PRO LYS LYS GLU HET IUV A 601 27 HETNAM IUV (5~{S},6~{R},7~{S},8~{S})-6,7,8-TRIS(OXIDANYL)-2-[2-[4- HETNAM 2 IUV (TRIFLUOROMETHYL)PHENYL]ETHYL]-5,6,7,8- HETNAM 3 IUV TETRAHYDROIMIDAZO[1,2-A]PYRIDINE-5-CARBOXYLIC ACID FORMUL 3 IUV C17 H17 F3 N2 O5 FORMUL 4 HOH *13(H2 O) HELIX 1 AA1 ARG A 167 SER A 180 1 14 HELIX 2 AA2 SER A 201 LYS A 214 1 14 HELIX 3 AA3 GLU A 225 ASN A 227 5 3 HELIX 4 AA4 SER A 228 ASP A 234 1 7 HELIX 5 AA5 ASN A 238 LYS A 255 1 18 HELIX 6 AA6 ARG A 272 GLY A 287 1 16 HELIX 7 AA7 GLU A 288 ILE A 290 5 3 HELIX 8 AA8 GLU A 308 LEU A 311 5 4 HELIX 9 AA9 ASN A 312 ASP A 317 1 6 HELIX 10 AB1 ASP A 317 SER A 332 1 16 HELIX 11 AB2 THR A 358 ALA A 360 5 3 HELIX 12 AB3 ALA A 361 GLY A 376 1 16 HELIX 13 AB4 LEU A 401 LEU A 413 1 13 HELIX 14 AB5 PRO A 469 LYS A 473 5 5 HELIX 15 AB6 HIS A 486 SER A 490 5 5 HELIX 16 AB7 VAL A 539 ILE A 543 5 5 HELIX 17 AB8 ASN B 64 ASP B 68 5 5 HELIX 18 AB9 ARG B 70 SER B 77 1 8 HELIX 19 AC1 SER B 77 LEU B 87 1 11 HELIX 20 AC2 GLY B 96 ASP B 100 5 5 SHEET 1 AA1 2 SER A 163 SER A 166 0 SHEET 2 AA1 2 LEU B 102 ASP B 105 1 O ASP B 105 N TYR A 165 SHEET 1 AA2 9 LEU A 182 LEU A 188 0 SHEET 2 AA2 9 SER A 219 LEU A 222 1 O SER A 219 N PHE A 186 SHEET 3 AA2 9 LEU A 263 VAL A 268 1 O TYR A 264 N TRP A 220 SHEET 4 AA2 9 SER A 292 ASN A 301 1 O HIS A 296 N VAL A 268 SHEET 5 AA2 9 VAL A 339 TYR A 348 1 O TRP A 340 N VAL A 293 SHEET 6 AA2 9 VAL A 379 GLN A 383 1 O VAL A 379 N LEU A 341 SHEET 7 AA2 9 LEU B 57 ASP B 62 1 O SER B 58 N VAL A 380 SHEET 8 AA2 9 ALA B 90 GLY B 95 1 O ARG B 93 N ILE B 61 SHEET 9 AA2 9 LEU A 182 LEU A 188 1 N ILE A 185 O LEU B 92 SHEET 1 AA3 4 LEU A 498 THR A 499 0 SHEET 2 AA3 4 VAL A 493 LEU A 495 -1 N LEU A 495 O LEU A 498 SHEET 3 AA3 4 VAL A 475 PRO A 482 -1 N ARG A 481 O GLN A 494 SHEET 4 AA3 4 LYS A 514 LEU A 516 -1 O LEU A 516 N VAL A 475 SHEET 1 AA4 8 LEU A 498 THR A 499 0 SHEET 2 AA4 8 VAL A 493 LEU A 495 -1 N LEU A 495 O LEU A 498 SHEET 3 AA4 8 VAL A 475 PRO A 482 -1 N ARG A 481 O GLN A 494 SHEET 4 AA4 8 SER A 528 ILE A 534 -1 O VAL A 533 N ASP A 476 SHEET 5 AA4 8 LEU A 450 ASN A 456 -1 N LEU A 452 O PHE A 532 SHEET 6 AA4 8 LEU A 431 THR A 438 -1 N HIS A 436 O THR A 451 SHEET 7 AA4 8 VAL A 414 VAL A 418 -1 N GLY A 415 O CYS A 437 SHEET 8 AA4 8 HIS B 50 LEU B 51 -1 O HIS B 50 N VAL A 418 SHEET 1 AA5 4 MET A 420 VAL A 423 0 SHEET 2 AA5 4 VAL B 38 PHE B 44 -1 O ASP B 42 N SER A 422 SHEET 3 AA5 4 LYS A 462 ARG A 465 1 N ARG A 465 O VAL B 39 SHEET 4 AA5 4 LEU A 522 LEU A 524 -1 O LEU A 524 N LYS A 462 SSBOND 1 CYS A 437 CYS A 542 1555 1555 2.05 CISPEP 1 GLY A 265 PRO A 266 0 6.37 CISPEP 2 GLN A 383 VAL A 384 0 -9.55 CISPEP 3 TYR A 468 PRO A 469 0 3.80 CISPEP 4 GLY A 484 PRO A 485 0 1.59 CISPEP 5 SER B 88 PRO B 89 0 6.09 CRYST1 49.974 60.090 78.423 90.00 89.16 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020010 0.000000 -0.000294 0.00000 SCALE2 0.000000 0.016642 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012753 0.00000